Sigurdur Oli Olafsson is an Icelandic businessperson who has been the head of 5 different companies. Presently, he occupies the position of Chief Executive Officer & Director at Hikma Pharmaceuticals Plc.
He is also on the board of The American-Scandinavian Foundation.
He previously was Chairman of Elucida Oncology, Inc., Director at Allergan Plc Chief Executive Officer at Actavis Group hf, Chief Executive Officer of Actavis, Inc. and Global Vice President-Investor Relations at Actavis, Inc. (which are all subsidiaries of Allergan Plc), Principal at Pfizer Inc. and Principal at Pfizer Ltd. (a subsidiary of Pfizer Inc.), President of Actavis Pharma, Inc., Head-Drug Development at Omega Farma ehf and President & CEO-Global Generic Medicines at Teva Pharmaceuticals Ltd.
Sigurdur Oli Olafsson received a graduate degree from the University of Iceland.